Comparative proteomics of inner membrane fraction from Carbapenem-resistant Acinetobacter baumannii with a reference strain

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Tiwari, Vishvanath ^a   Vashistt, Jitendraa ^a   Kapil, Arti ^a   Moganty, Rajeswari R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAMASE; BETA LACTAMASE AMPC; CARBAPENEM; DIHYDROLIPOAMIDE DEHYDROGENASE; ELONGATION FACTOR TU; IMIPENEM; MALATE DEHYDROGENASE; MEMBRANE ANTIGEN; OXOGLUTARATE DEHYDROGENASE; PROTEIN OMPW; PROTEIN OXA 51; PROTEIN OXA 71; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CONTROLLED STUDY; DIFFERENTIAL IN GEL ELECTROPHORESIS; DOWN REGULATION; ENERGY YIELD; GEL ELECTROPHORESIS; GENE OVEREXPRESSION; LIQUID CHROMATOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; PROTEOMICS; TANDEM MASS SPECTROMETRY; UPREGULATION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CARBAPENEMS; DOWN-REGULATION; DRUG RESISTANCE, BACTERIAL; PROTEOMICS; TANDEM MASS SPECTROMETRY; UP-REGULATION;

EID: 84862729225     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039451     Document Type: Article

References (57)

1. Maragakis LL, Perl TM, (2008) Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46: 1254-1263.
2. Karageorgopoulos DE, Falagas ME, (2008) Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 8: 751-762.
3. Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez FJ, Perez-Paredes C, (2001) Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin Infect Dis 33: 939-946.
4. Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez FJ, Monterrubio-Villar J, (1999) Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med 27: 1794-1799.
5. Suri A, Mahapatra AK, Kapil A, (2000) Acinetobacter infection in neurosurgical intensive care patients. Natl Med J India 13: 296-300.
6. Gupta E, Mohanty S, Sood S, Dhawan B, Das BK, et al. (2006) Emerging resistance to carbapenems in a tertiary care hospital in north India. Indian J Med Res 124 (1): 95-8.
7. Chuang YC, Chang SC, Wang WK, (2010) High and increasing Oxa-51 DNA load predict mortality in Acinetobacter baumannii bacteremia: implication for pathogenesis and evaluation of therapy. PLoS ONE 5(11): e14133.
8. Falagas ME, Kopterides P, Siempos I, (2006) Attributable mortality of Acinetobacter baumannii infection among critically ill patients. Clin Infect Dis 43: 389-390.
9. Fishbain J, Peleg AY, (2010) Treatment of Acinetobacter infections. Clin Infect Dis 51: 79-84.
10. Vila J, Pachon J, (2008) Therapeutic options for Acinetobacter baumannii infections. Expert Opin Pharmacother 9(4): 587-99.
11. Vashist J, Tiwari V, Kapil A, Rajeswari MR, (2010) Quantitative profiling and identification of outer membrane proteins of β-Lactam resistant strain of Acinetobacter baumannii. J Proteome Res 9: 1121-1128.
12. Vashist J, Tiwari V, Das R, Kapil A, Rajeswari MR, (2011) Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii. Indian J Med Res 133: 332-338.
13. Peleg AY, Seifert H, Paterson DL, (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21: 538-582.
14. Fernandez-Cuenca F, Martinez-Martinez L, Conejo MC, Ayala JA, Perea EJ, et al. (2003) Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemoth 51: 565-74.
15. Kohlenberg A, Brummer S, Higgins PG, Sohr D, Piening BC, et al. (2009) Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. J Med Microbiol 58: 1499-1507.
16. Vila J, Mart S, Sanchez-Cespedes J, (2007) Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemoth 59: 1210-1215.
17. Siroy A, Costette P, Seyer D, Lemaitra-Guillier C, Vallent D, et al. (2006) Global comparison of the membrane subproteomes between a multidrug resistant Acinetobacter baumannii strain and a reference strain. J Proteome Res 5: 3385-3398.
18. Siroy A, Molle V, Lemaitre-Guillier C, Vallent D, Pestelcaron M, et al. (2005) Channel formation by CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii. Antimicrob Agents Chemother 49: 4876-83.
19. Fernandez-Reyes M, Rodriguez-Falcon M, Chiva C, Pachon J, Andreu D, et al. (2009) The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective. Proteomics 9: 1632-45.
20. Yun SH, Choi CW, Kwon S, Park GW, Cho K, et al. (2011) Quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrug resistant Acinetobacter baumannii. J Proteome Res 10 (2): 459-69.
21. Shin JH, Lee HW, Kim SM, Kim J, (2009) Proteomic analysis of Acinetobacter baumannii in biofilm and planktonic growth mode. J Microbiol 47(6): 728-35.
22. Constantiniu S, Romaniuc A, Iancu LS, Filimon R, Taraşi I, (2004) Cultural and biochemical characteristics of Acinetobacter spp. strains isolated from hospital units. J Prevent Med 12: 35-42.
23. Filip C, Fletcher G, Wulff JL, Earhart CF, (1973) Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium lauryl sarcosinate. J Bacteriol 115 (3): 717-722.
24. Pieper R, Huang S, Clark DJ, Robinson JM, Alami H, et al. (2009) Integral and peripheral association of proteins and protein complexes with Yersinia pestis inner and outer membranes. Proteome Sci 7: 5.
25. Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, et al. (2003) A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3(1): 36-44.
26. Alteri CJ, Mobley HLT, (2007) Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect Immun 75 (6): 2679-2688.
27. Bisle B, Schmidt A, Scheibe B, Klein C, Tebbe A, et al. (2006) Quantitative profiling of the membrane proteome in a halophilic archaeon. Mol Cell Proteomics 5 (9): 1543-1558.
28. Kang Y, Techanukul T, Mantalaris A, Nagy JM, (2009) Comparison of three commercially available DIGE analysis software packages: minimal user intervention in gel-based proteomics. J Proteome Res 8 (2): 1077-1084.
29. Fan Y, Murphy TB, Byrne JC, Brennan L, Fitzpatrick JM, (2011) Applying random forests to identify biomarker panels in serum 2D-DIGE data for the detection and staging of prostate cancer. J Proteome Res 10: 1361-1373.
30. Lee H, Chenb C, Wangb S, Sud L, Chenb S, et al. (2011) Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implications. Int J Antimicrob Agents 37: 302-308.
31. Santos KV, Carvalho MA, Martins WA, Andrade HM, Veloso LC, et al. (2011) Phenotypic changes in a laboratory-derived ertapenem-resistant Escherichia coli strain. J Chemother 23(3): 135-9.
32. Seneviratne CJ, Wang Y, Jin L, Abiko Y, Samaranayake LP, (2010) Proteomics of drug resistance in Candida glabrata biofilms. Proteomics 10: 1444-1454.
33. Martínez-Martínez L, Pascual A, Hernández-Allés S, Alvarez-Díaz D, Suárez AI, et al. (1999) Roles of β-Lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumonia. Antimicrob Agents Chemother 43(7): 1669-1673.
34. Rodríguez-Martínez J, Poirel L, Nordmann P, (2010) Genetic and functional variability of AmpC-Type β-Lactamases from Acinetobacter baumannii. Antimicrob Agents Chemother 54 (11): 4930-4933.
35. Heritier C, Poirel L, Nordmann P, (2006) Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin Micro Infect 12(2): 123-130.
36. Tiwari V, Kapil A, Moganty RR, (2012) Carbapenem-hydrolyzing Oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India. Microb Pathogenesis: In press (DOI: 10.1016/j.micpath.2012.05.004).
37. Brown S, Young H K, Amyes SGB, (2005) Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect 11: 11-5.
38. Costa L, Coelho MJM, Souza HAPHM, Castro MES, Stier CJN, et al. (2003) Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microbiol 41: 3403-3406.
39. Figueiredo S, Poirel L, Papa A, Koulourida V, Nordmann P, (2009) Overexpression of the naturally occurring blaOXA-51 Gene in Acinetobacter baumannii Mediated by Novel Insertion Sequence ISAba9. Antimicrob Agents Chemother 53(9): 4045-4047.
40. Figueiredo S, Poirel L, Croize J, Recule C, Nordmann P, (2009) In Vivo selection of reduced susceptibility to carbapenems in acinetobacter baumannii related to ISAba1-mediated overexpression of the natural blaOXA-66 oxacillinase gene. Antimicrob Agents Chemother 53(6): 2657-2659.
41. Madeira A, Santos PM, Coutinho CP, Pinto-de-Oliveira A, Sa-Correia I, (2011) Quantitative proteomics (2-D DIGE) reveals molecular strategies employed by Burkholderia cenocepacia to adapt to the airways of cystic fibrosis patients under antimicrobial therapy. Proteomics 11: 1313-1328.
42. Stenberg F, Chovanec P, Maslen SL, Robinson CV, Ilag LL, et al. (2005) Protein complexes of the Escherichia coli cell envelope. J Bio Chem 280(41): 34409-34419.
43. Marti S, Sanchez-Cespedes J, Oliveira E, Bellido D, Giralt E, et al. (2006) Proteomic analysis of a fraction enriched in cell envelope proteins of Acinetobacter baumannii. Proteomics 6: S82-S87.
44. Soares NC, Cabral MP, Parreira JR, Gayoso C, Barba MJ, et al. (2009) 2-DE analysis indicates that Acinetobacter baumannii displays a robust and versatile metabolism. Proteome Sci 7: 37.
45. Santos KV, Diniz CG, Veloso LC, Andrade HM, Giusta MS, et al. (2010) Proteomic analysis of Escherichia coli with experimentally induced resistance to piperacillin/tazobactam. Res Microbiol 161: 268-275.
46. Shen CJ, Kuo TY, Lin CC, Chow LP, Chen WJ, (2010) Proteomic identification of membrane proteins regulating antimicrobial peptide resistance in Vibrio parahaemolyticus. J Appl Microbiol 108(4): 1398-407.
47. Kim K, Lee S, Lee K, Lim D, (1998) Isolation and characterization of toluene-sensitive mutants from the toluene-resistant bacterium Pseudomonas putida GM73. J Bacteriol 180(14): 3692-3696.
48. Castro ME, Molina RC, Díaz WA, Pradenas GA, Vásquez CC, (2009) Expression of Aeromonas caviae ST pyruvate dehydrogenase complex components mediate tellurite resistance in Escherichia coli. Biochem Biophys Res Commun 380: 148-152.
49. Echave P, Tamarit J, Cabiscol E, Ros J, (2003) Novel antioxidant role of alcohol dehydrogenase from Escherichia coli. J Biol Chem 278(32): 30193-30198.
50. Breckau D, Mahlitz E, Sauerwald A, Gunhild L, Dieter J, (2003) Oxygen-dependent coproporphyrinogen III oxidase (HemF) from Escherichia coli is stimulated by manganese. J Biol Chem 278(47): 46625-46631.
51. Nieves W, Heang J, Asakrah S, Bentrup KH, Roy CJ, et al. (2010) Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization. PLoS ONE 5(12): e14361.
52. Harms JM, Bartels H, Schlünzen F, Yonath A, (2003) Antibiotics acting on the translational machinery. J Cell Sci 116: 1391-1393.
53. Garduno RA, Chong A, Nasrallah GK, Allan DS, (2011) The Legionella pneumophila chaperonin- an unusual multifunctional protein in unusual locations. Front Microbiol 2: 122.
54. Cardoso K, Gandra RF, Wisniewski ES, Osaku CA, Kadowaki MK, et al. (2010) DnaK and GroEL are induced in response to antibiotic and heat shock in Acinetobacter baumannii. J Med Microb 59: 1061-1068.
55. Kovacs-Simon A, Titball RW, Michell SL, (2011) Lipoproteins of bacterial pathogens. Infect Immun 79(2): 548-561.
56. Nikaido H, (1999) Microdermatology: Cell surface in the interaction of microbes with the external world. J Bacteriol 181 (1): 4-8.
57. Hong H, Patel DR, Tamm LK, Berg B, (2006) The outer membrane protein OmpW forms an eight-stranded β-Barrel with a hydrophobic channel. J Biol Chem 281(11): 7568-7577.